The association between fasting hypoglycemia and methylated mercaptopurine metabolites in children with acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 61, Issue 6, 2014, Pages 1003-1006

  Melachuri, Samyuktha ^a   Gandrud, Laura ^a   Bostrom, Bruce ^a  

^a CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

Author keywords

6 mercaptopurine; 6MMP; ALL; ALT; Hypoglycemia; Thiopurine metabolites

Indexed keywords

6 METHY MERCAPTOPURINE; CARBOHYDRATE; DEXAMETHASONE; GLUCOSE; INSULIN; MERCAPTOPURINE; METFORMIN; PURINE DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLOOD GLUCOSE MONITORING; CARBOHYDRATE INTAKE; CASE REPORT; CHILD; CHILDHOOD DISEASE; DIET RESTRICTION; DIZZINESS; DRUG INDUCED HEADACHE; ENZYME ACTIVITY; EVENING DOSAGE; FATIGUE; FEMALE; GENERAL CONDITION DETERIORATION; GLUCOSE BLOOD LEVEL; HAIR LOSS; HUMAN; HYPOGLYCEMIA; MAINTENANCE THERAPY; MALE; MEDICAL RECORD REVIEW; METABOLITE; MORNING DOSAGE; PALLOR; PRIORITY JOURNAL; TACHYCARDIA;

6-MERCAPTOPURINE; 6MMP; ALL; ALT; HYPOGLYCEMIA; THIOPURINE METABOLITES;

6-MERCAPTOPURINE; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOTRANSFORMATION; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DEXAMETHASONE; DIETARY CARBOHYDRATES; DRUG ADMINISTRATION SCHEDULE; FASTING; FEMALE; GUANINE NUCLEOTIDES; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INFANT; LIVER GLYCOGEN; MAINTENANCE CHEMOTHERAPY; MALE; METHOTREXATE; METHYLATION; METHYLTRANSFERASES; POLYMORPHISM, GENETIC; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRODRUGS; RETROSPECTIVE STUDIES; THIONUCLEOTIDES;

EID: 84901719408     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24928     Document Type: Article

References (11)

1. Bostrom B, Erdmann G. Cellular pharmacology of 6-mercaptopurine in acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 1993; 15:80-86.
2. Brouwer C, De Abreu RA, Keizer-Garritsen JJ, et al. Thiopurine methyltransferase in acute lymphoblastic leukaemia: Biochemical and molecular biological aspects. Eur J Cancer 2005; 41:613-623.
3. Shih DQ, Nguyen M, Zheng L, et al. Split-dose administration of thiopurine drugs: A novel and effective strategy for managing preferential 6-MMP metabolism. Aliment Pharmacol Ther 2012; 36:449-458.
4. Halonen P, Salo M, Makipernaa A. Fasting hypoglycemia is common during maintenance therapy for childhood acute lymphoblastic leukemia. J Pediatr 2001; 138:428-431.
5. Bay A, Oner AF, Cesur Y, et al. Symptomatic hypoglycemia: An unusual side effect of oral purine analogues for treatment of ALL. Pediatr Blood Cancer 2006; 47:330-331.
6. Visavachaipan N, Aledo A, Brar PC, et al. Continuous glucose monitoring: A valuable monitoring tool for management of hypoglycemia during chemotherapy for acute lymphoblastic leukemia. Diabetes Technol Ther 2013; 15:97-100.
7. Gluconeogenesis: Glucose synthesis, the medical biochemistry page (3/7/2013).
8. Nygaard U, Toft N, Schmiegelow K. Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity. Clin Pharmacol Ther 2004; 75:274-281.
9. Bell BA, Erdmann G, Bostrom B, et al. A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: A Pediatric Oncology Group study (now The Children's Oncology Group). Pediatr Blood Cancer 2004; 43:105-109.
10. Riccardi R, Balis FM, Ferrara P, et al. Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol 1986; 3:319-324.
11. Rivard GE, Infante-Rivard C, Hoyoux C, et al. Maintenance chemotherapy for childhood acute lymphoblastic leukaemia: Better in the evening. Lancet 1985; 2:1264-1266.